Exchange: OTC·Updated 10:59 AM EDT

ORGS Orgenesis Inc

$0.0327
$0.00
(0.00%)
Today
Reported EarningsNov 13
Mkt Cap$320,445.00
Vol100.00

About ORGS

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point-of-care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
50

Neutral Sentiment

How do you feel about ORGS?

Advertisement|Remove ads.